Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 40
Age Group: 18 Years to 85 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: MPM phase II Carbo/VNB
Study First Received: January 3, 2006
Last Updated: September 17, 2009
Estimated Primary Completion Date: September 2009
Primary Outcome Measures:
Response|Survival|Feasibility
Sponsors and Collaborators:
Rigshospitalet, Denmark
Website Link: https://ClinicalTrials.gov/show/NCT00272558
